Bio Products Laboratory Report issue

Contributed to NME For profit Phase 1 Phase 3 Phase 4
Founded: Elstree United Kingdom (1954)
Status: No NME R&D (1954)

Organization Overview

First Clinical Trial
1997
NCT02263456
First Marketed Drug
2009
immune globulin (human) (Gamastan)
First NDA Approval
2015
human coagulation factor x (Coagadex)
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Bio Products Laboratory | Bio Products Laboratory Limited